VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug…Read More
You might also be interested in reading ALEX BRUMMER: Last hurrah for Royal Mail.